Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bluebird Bio (NQ: BLUE ) 0.6887 +0.0117 (+1.73%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bluebird Bio < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > AutoZone, bluebird bio And 3 Stocks To Watch Heading Into Monday September 19, 2022 With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Via Benzinga FDA Okays bluebird bio's $3M Gene Therapy For Rare Neurological Disorder In Boys: What Investors Should Know September 17, 2022 Biotechnology company, bluebird bio, Inc. (NASDAQ: BLUE) announced late Friday that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease. Via Benzinga Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin September 15, 2022 The market is struggling, yet biotech stocks are acting like it's good times again. Here's why. Via Investor's Business Daily Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know August 31, 2022 After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar. Via Benzinga What 4 Analyst Ratings Have To Say About bluebird bio August 18, 2022 Within the last quarter, bluebird bio (NASDAQ:BLUE) has observed the following analyst ratings: Via Benzinga Bluebird's Gene Therapy Scores US Approval For Genetic Blood Disorder, Probably The Most Expensive August 17, 2022 Via Benzinga 10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others August 29, 2022 These names are benefitting from M&A, clinical data and promising regulatory actions. Via Investor's Business Daily This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday August 19, 2022 Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. Via Benzinga Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session August 18, 2022 Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66. Via Benzinga Dear AAPL Stock Fans, Mark Your Calendars for Sept. 7 August 18, 2022 Fans of Apple (AAPL) stock will want to keep their calendars open for Sept. 7 as that's reportedly when its next event will take place. Via InvestorPlace BLUE Stock Moves as FDA Approves Bluebird Bio’s Gene Therapy August 18, 2022 Bluebird Bio (BLUE) stock is on the move Thursday following FDA approval for beta-thalassemia treatment ZYNTEGLO in adults and children. Via InvestorPlace Bed Bath & Beyond, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday August 18, 2022 Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 23.3% to $17.71 following a Form 144 filing by RC Ventures, which suggested the firm proposed to sell 7.78 million common shares and certain call options.... Via Benzinga Benzinga Before The Bell: Tesla Model Y Delivery Wait Time Shortened In China, Mark Zuckerberg's Sister Emphasizes On Evolution Of Web3, Amazon Succumbs To TikTok Fever And Other Top Financial Stories Thursday, August 18 August 18, 2022 CNBC Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session August 18, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday August 18, 2022 It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving! Via InvestorPlace This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving Premarket August 18, 2022 Gainers Via Benzinga Cisco, Keysight Technologies And Some Other Big Stocks Moving Higher In Today's Pre-Market Session August 18, 2022 Wolfspeed, Inc. (NYSE: WOLF) rose 20.7% to $103.40 in pre-market trading after the company reported better-than-expected Q4 results. Via Benzinga Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary August 17, 2022 Via Benzinga Bluebird Secures FDA Nod For Genetic Blood Disease Candidate August 17, 2022 The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ: BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult... Via Benzinga Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US August 09, 2022 Via Benzinga Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket August 09, 2022 Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D. Via Benzinga Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday August 10, 2022 Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. Via Benzinga Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session August 09, 2022 Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... Via Benzinga Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday August 08, 2022 Gainers Via Benzinga Expert Ratings for bluebird bio August 02, 2022 Over the past 3 months, 4 analysts have published their opinion on bluebird bio (NASDAQ:BLUE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 August 02, 2022 Upgrades Via Benzinga Biotech Investors: August's Key PDUFA Catalysts You Must Know July 31, 2022 Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session July 15, 2022 Via Benzinga 7 Oversold Stocks to Buy in July 2022 July 06, 2022 These are the best oversold stocks to buy in July. SQ, BLUE, CCI, ETSY, META, SWKS, and TWLO can make great investments. Via InvestorPlace Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names July 06, 2022 Biotech stocks continued going gangbusters Wednesday. Here's why, experts say. Via Investor's Business Daily < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.